Branded Legacy, Inc. Secures Key Client With $70,000,000 Annual Revenue; Expects to Surpass $10,000,000 in 2025
Branded Legacy, Inc. Secures Key Client With $70,000,000 Annual Revenue; Expects to Surpass $10,000,000 in 2025
500% Growth Target Has Been Set For The Next Six Months of Operations
已爲未來六個月的運營設定了500%的增長目標
MELBOURNE, Fla., Oct. 1, 2024 /PRNewswire/ -- Branded Legacy, Inc.,(OTC.PK: BLEG) a leading supplier of botanical extracts and alkaloid-based compounds, is excited to announce that it has sent its first invoice to Monster Group, Inc. a multinational product manufacturer and distributor generating over $70,000,000 in annual revenue. This partnership marks a significant milestone and is expected to act as a catalyst that will propel Branded Legacy into generating over $10,000,000 annually in revenue by 2025.
佛羅里達州墨爾本,2024年10月1日 /美通社/--Branded Legacy, Inc.,(場外交易: BLEG)植物提取物和生物鹼化合物領先供應商,激動地宣佈已向跨國產品製造商和分銷商Monster Group, Inc.發送了首張發票,該公司年營業收入超過7000萬美元。這一合作伙伴關係標誌着一個重要的里程碑,並預計將成爲一種催化劑,推動Branded Legacy到2025年年營收超過1000萬美元。
The partnership commences with Branded Legacy's subsidiary Sycamore BioPharma providing high-quality mitragynine salt, which will be integrated into the client's product lines which are sold across the Middle East, Europe, and North America. Branded Legacy will take over lab operations for this client over the next 6 to 10 months. The current supply line is generating approximately $60,000 weekly for the company, and a 500% growth target has been set for the next six months of operations. Discussions for expanding the product line with several additional commodities are already underway.
該合作伙伴關係由Branded Legacy的子公司Sycamore BioPharma提供高質量的米特拉吉寧鹽開啓,將會融入客戶在中東、歐洲和北美銷售的產品線中。Branded Legacy將在接下來的6至10個月內接管該客戶的實驗室運營。目前的供應線每週爲公司帶來約6萬美元的收入,對未來六個月的運營設定了500%的增長目標。與多種其他商品擴大產品線的討論已經展開。
In addition, Branded Legacy's subsidiary Royal Biotek has been engaged in negotiations with a large distributor to provide Delta 8 and Delta 9 distillate, which could lead to similar revenue figures in the near future.
此外,Branded Legacy的子公司Royal Biotek已與一家大型經銷商展開談判,向其提供Delta 8和Delta 9蒸餾液,這可能在不久的將來帶來類似的營收額。
"This announcement is the culmination of months of dedicated work and negotiations," said Dave Oswald, CEO of Branded Legacy, Inc. "While we have always been cautious about sharing sensitive deal information until it's finalized, I'm pleased to confirm that this development positions us to be a self-funded company moving forward, reducing the need to seek additional funding."
"這一公告是數月來的專注工作和談判的結果,"Branded Legacy, Inc.的CEO大衛·奧斯瓦爾德表示:"雖然我們一直對分享敏感的交易信息持謹慎態度,直至最終敲定之前,但我很高興確認這一進展使我們能夠自行資助,減少了尋求額外資金的需求。"
Branded Legacy has also been in talks with several potential acquisition candidates, with discussions accelerating rapidly. These candidates include companies that complement Branded Legacys' existing operations and strategic growth plans.
Branded Legacy還與多家潛在收購候選者進行了會談,討論正在迅速加速。這些候選者包括與Branded Legacy現有業務和戰略增長計劃相輔相成的公司。
About Branded Legacy, Inc.
Branded Legacy, Inc. is a leading supplier of botanical extracts, specializing in high-quality, sustainable ingredients for use in supplements and wellness products..
關於Branded Legacy, Inc.
Branded Legacy, Inc.是一家主要供應植物提取物的領先公司,專門提供用於補充劑和健康產品的高質量、可持續的成分。
Original Copy of this Press Release:
此新聞稿的原始副本:
For more information, please contact:
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: [email protected]
更多信息,請聯繫:
Joe Holladay
Branded Legacy
電話:321-345-3565
電子郵件:[email protected]
Website:
網站:
Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services, including ventures in biotechnology, digital solutions, and wellness products.
Branded Legacy, Inc. (場外交易: BLEG) 是一家多元化控股公司,專注於生物技術板塊。Branded Legacy致力於卓越與創新,在生物技術、數字解決方案和健康產品的開發和營銷方面有所專長。
Safe Harbor Statement on Forward-Looking Language:
關於前瞻性語言的安全港聲明:
This release includes forward-looking statements, subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The company disclaims any intention or obligation to update or revise forward-looking statements. Forward-looking statements may be identified by words such as "may," "will," "expect," "believe," "anticipate," "estimate," and similar expressions.
本發佈包含前瞻性聲明,受風險和不確定性影響,可能導致實際結果與當前預期大相徑庭。公司不承擔更新或修改前瞻性聲明的意圖或義務。前瞻性聲明可通過"可能"、"將"、"預期"、"相信"、"預計"、"估計"等詞彙識別。
SOURCE Branded Legacy, Inc.
資料來源:Branded Legacy, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎?
譯文內容由第三人軟體翻譯。